Clinical Trial Update: Diosmin as Adjuvant Therapy in Treatment of Non-bleeding Peptic Ulcer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating diosmin as adjuvant therapy for non-bleeding peptic ulcer; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-bleeding Peptic Ulcer

Drugs mentioned

• Diosmin (Diosmin)

Snippet

Sponsor: Tanta University | Conditions: Non-bleeding Peptic Ulcer | Phase 3 | Status: UNKNOWN